Literature DB >> 16485066

Insulin-like growth factors (IGF) I and II utilize different calcium signaling pathways in a primary human parathyroid cell culture model.

C K M Wong1, T Lai, J M P Holly, M H Wheeler, C E H Stewart, J R Farndon.   

Abstract

BACKGROUND: In most cell types, influx of calcium (Ca2+) induces a growth or secretory response. The opposite occurs in parathyroid (PTH), cells where there is an inverse relationship between intracellular Ca2+ concentration and PTH secretion. We have examined the effects of calcium channel and metabolism modulators on insulin-like growth factors (IGFs) in a parathyroid cell culture model.
METHODS: Cell cultures were prepared from 9 patients undergoing operation for hyperparathyroidism. Following adhesion, the cells were transferred to serum-free medium and dosed with IGF I, II +/- ethyleneglycol-bis(beta-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA), nifedipine, nickel, 2-aminoethoxy-diphenylborate (2-APB), or dantrolene. Proliferation (96 hours) was assessed by measuring tritiated thymidine incorporation and PTH release (1 and 3 hours) assayed by IRMA.
RESULTS: Both IGF I and II increased DNA synthesis to 162.8% +/- 10.6% (SEM) and 131.1% +/- 7.7%, respectively (P < 0.05). EGTA at 0.2 mmol (ionized Ca2+ 0.2 mmol) did not affect the response to both IGFs. EGTA at 2 mmol (ionized Ca2+ 0 mmol) reduced the DNA synthesis of IGF I and II to 29% and 26%, respectively (P < 0.05). Nifedipine and nickel (nonspecific Ca2+ channel blocker) were equally potent in negating the mitogenic effects of both IGFs. 2-APB (IP3R blocker) reduced the basal DNA synthesis to 51.3% +/- 8.4% but had no effect on either IGF. Dantrolene (ryanodine receptor blocker) negated IGF II induced mitogenisis (74.2% +/- 6.7%) and partially inhibited IGF I mitogenesis (123% +/- 6%) (P < 0.05). The rate of PTH secretion was greater after IGF II stimulation than after IGF I stimulation.
CONCLUSIONS: IGFs I and II induce mitogenesis by different calcium signaling pathways. These data suggest that parathyroid cells may utilize different calcium signaling pathways to distinguish growth factors and serum calcium changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16485066     DOI: 10.1007/s00268-005-0339-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  80 in total

Review 1.  Calcium channels in vertebrate cells.

Authors:  P Hess
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

Review 2.  The intracellular distribution of calcium.

Authors:  J Meldolesi; P Volpe; T Pozzan
Journal:  Trends Neurosci       Date:  1988-10       Impact factor: 13.837

Review 3.  The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel.

Authors:  K P Campbell; A T Leung; A H Sharp
Journal:  Trends Neurosci       Date:  1988-10       Impact factor: 13.837

Review 4.  Calcium entry and activation of endocrine cells.

Authors:  W J Malaisse
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Authors:  F Frasca; G Pandini; P Scalia; L Sciacca; R Mineo; A Costantino; I D Goldfine; A Belfiore; R Vigneri
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Calcium channels. Structure and selectivity.

Authors:  G Yellen
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

7.  Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor.

Authors:  D Meyer zu Heringdorf; H Lass; I Kuchar; R Alemany; Y Guo; M Schmidt; K H Jakobs
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

8.  In vivo effect of endothelin-1 on plasma calcium and parathyroid hormone concentrations.

Authors:  J M Chang; S J Hwang; J C Tsai; Y H Lai
Journal:  J Endocrinol       Date:  2000-05       Impact factor: 4.286

9.  Insulin-like growth factor I stimulates inositol phosphate accumulation, a rise in cytoplasmic free calcium, and proliferation in cultured porcine thyroid cells.

Authors:  N Takasu; M Takasu; I Komiya; Y Nagasawa; T Asawa; Y Shimizu; T Yamada
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

10.  Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors.

Authors:  R Tanaka; T Tsushima; H Murakami; K Shizume; T Obara
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more
  6 in total

1.  Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; Melissa E Danko; Sandra Stinnett; Darshana Dixit; James Koh; Jeffrey R Marks; John A Olson
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

2.  Role of growth factors on human parathyroid adenoma cell proliferation.

Authors:  Giuseppe Cavallaro; Alessandra Cucina; Pierpaolo Coluccia; Luigi Petramala; Dario Cotesta; Andrea Polistena; Laura Zinnamosca; Claudio Letizia; Lodovico Rosato; Antonino Cavallaro; Giorgio De Toma
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

3.  Secretion of parathyroid hormone may be coupled to insulin secretion in humans.

Authors:  Marie Reeberg Sass; Nicolai Jacob Wewer Albrechtsen; Jens Pedersen; Kristine Juul Hare; Nis Borbye-Lorenzen; Katalin Kiss; Tina Vilsbøll; Filip Krag Knop; Steen Seier Poulsen; Niklas Rye Jørgensen; Jens Juul Holst; Cathrine Ørskov; Bolette Hartmann
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

4.  Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.

Authors:  M Cecilia Ortiz-Capisano; Mahendranath Reddy; Mariela Mendez; Jeffrey L Garvin; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

5.  Igf-I influences everolimus activity in medullary thyroid carcinoma.

Authors:  Erica Gentilin; Carmelina Di Pasquale; Martina Rossi; Federico Tagliati; Teresa Gagliano; Roberta Rossi; Mariarosa Pelizzo; Isabella Merante Boschin; Ettore C Degli Uberti; Maria Chiara Zatelli
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-05       Impact factor: 5.555

6.  The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III.

Authors:  Mieke Van Hemelrijck; Thurkaa Shanmugalingam; Cecilia Bosco; Wahyu Wulaningsih; Sabine Rohrmann
Journal:  Endocr Connect       Date:  2015-09       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.